HOME >> MEDICINE >> NEWS
The Burroughs Wellcome Fund awards $8 million to infectious disease investigators

RESEARCH TRIANGLE PARK, N.C. -- When the 16 recipients of the Burroughs Wellcome Fund's Investigators in Pathogenesis of Infectious Disease award were notified that they had received the award, there was more good news. The award amount had increased to $500,000 over a five-year period from $400,000.

The Investigators in Pathogenesis of Infectious Disease awards are made to encourage aggressive, multidisciplinary approaches to investigating pathogenesis. BWF launched the program in 2002 and has made 58 awards for an investment of approximately $24.8 million in the careers of investigators who are working on understanding the interaction between the human host and the infectious agentbacterial, viral, fungal, or parasitic.

All awardees hold tenure-track faculty positions and must be nominated by degree-granting institutions in the United States or Canada.

"The constant threat of infectious disease is of global concern, BWF President Dr. Enriqueta Bond said. "Understanding the underlying principles of how the microbial world interacts with the human host is of paramount importance. We are pleased to play a role in the expansion of knowledge in this important scientific field.

Following are the 2007 award recipients, along with their institutions and research projects:

Benjamin K. Chen, M.D., Ph.D.
Mount Sinai School of Medicine
Dissemination of HIV through virological synapses

Andrew Darwin, Ph.D.
New York University School of Medicine
Mechanisms of Pseudomonas aeruginosa tolerance to secretin-induced stress during host infection

Michael R. Farzan, Ph.D.
Harvard Medical School
Parallel identification of obligate viral receptors

Britt Glaunsinger, Ph.D.
University of California-Berkeley
Global modulation of cellular gene expression by an oncogenic human herpesvirus

Karen J. Guillemin, Ph.D.
University of Oregon
Reg
'"/>

Contact: Russ Campbell
news@bwfund.org
919-991-5119
Burroughs Wellcome Fund
4-Jun-2007


Page: 1 2

Related medicine news :

1. Wellcome brain insights
2. University hospitals wins multiple national IT awards for electronic patient data bank
3. CIRM awards $3.79 million to Burnham Institute
4. Gerontological Society of America awards new Hartford Doctoral Fellowships
5. AACR awards minority and other underrepresented scientists
6. FNSNA awards $25,000 grant to Rutgers College of Nursing
7. International and American Associations for Dental Research present awards and fellowships
8. JDRF awards Emory $2.5 million to develop islet transplant technology
9. NIH awards $1 million to Temple University Hospital for neurological treatment studies
10. NHLBI awards 12 Womens Health Initiative contracts
11. The Gerontological Society of America awards new Hartford Doctoral Fellowships

Post Your Comments:
(Date:4/24/2015)... (PRWEB) April 24, 2015 The 1975 ... toured almost constantly across the globe to theaters, festivals and ... in Manchester, they’ve partnered with their label, Dirty Hit Records, ... Teaming up with the newly launched Cadence & Cause ... their debut LP on vinyl and a signed photo card. ...
(Date:4/24/2015)... April 24, 2015 Lowcostcarinsuranceprice.com has released ... low cost auto insurance for senior citizens . ... but this does not mean that they cannot find ... senior drivers can find the right coverage for their ... brokerage website like http://lowcostcarinsuranceprice.com/ provides free leads ...
(Date:4/24/2015)... Integrative Therapeutics has introduced two new supplements focused ... A unique combination of herbs and nutrients, including ... apart from other antioxidant supplements. This formula relies ... versus the use of single or sequential compounds ... Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 with Setria® Glutathione. ...
(Date:4/24/2015)... With years of experience providing consumer ... to be partnered with a veterinary college where veterinary ... This partnership has brought new payment options for families ... providing an in-house payment plan for many years, the ... to increase financing options available to avoid having to ...
(Date:4/24/2015)... 2015 IntelliSoft Group, LLC, a ... contract management software, featured IntelliCred Version 14.2 during ... Annual Educational Conference (IAMSS) on April 23-24 ... Brook, Illinois. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection ...
Breaking Medicine News(10 mins):Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2
(Date:4/24/2015)... 2015 Research and Markets ... of the "Lab Accessories Market by ... Station) & End User (OEM/Biotechnology & Pharmaceutical ... 2020" report to their offering. ... expected to reach $504.7 million by 2020 ...
(Date:4/24/2015)... Company, Inc. (NYSE: LCI ) today announced that ... facility to $120 million from $50 million.  The amended ... company to increase borrowings by a total of up ... commitments from existing lenders or new lending institutions.  The ... 2018.   "The amended credit facility, together ...
(Date:4/23/2015)... CHICAGO, Ill. , April 24, 2015  AbbVie ... Food and Drug Administration (FDA) has accepted its New ... company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, ... for the treatment of adults with chronic genotype 4 ... regimen is the first all-oral, interferon-free therapy being evaluated ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
Cached News: